Strong Reported and Normalized Profit Growth
Reported profit of EUR 943 million for 2025, up 44% year-on-year; normalized profit EUR 907 million, up 5% year-on-year. Normalized EPS EUR 0.36, reported EPS up ~3% post AT1 coupon.
Robust Credit and Deposit Growth
Net credit expansion EUR 3.5 billion for the year (performing loans EUR 37.5 billion), performing loans up 5% quarter-on-quarter and 8.3% year-on-year. Deposits increased by EUR 4 billion for the year (customer funds +8.4% year-on-year).
Significant Fee Momentum and AUM Growth
Fees reported EUR 510 million in 2025 with strong Q4 performance (fees +19% Q/Q excluding AstroBank). Net AUM sales EUR 1.3 billion for the year and AUM growth ~21% including valuation; fees expected ~EUR 600 million in 2026 (fees >25% of revenues).
Capital Generation and Returns
Organic capital generation of 206 basis points for FY2025, quarterly organic capital generation 52 bps. Return on tangible equity 11.9% reported and 13.8% normalized.
Shareholder Distributions and Capital Return Policy
Proposed ordinary payout of 55% of 2025 reported profits = EUR 519 million in distributions (yield ~6.1% on current market cap). Plan to split ordinary payout equally between cash dividend (final dividend ~EUR 148 million, ~EUR 0.065 per share) and a EUR 259 million buyback.
Disciplined, Accretive M&A Execution
Completed acquisitions (AstroBank, Flexfin, AXIA) and announced Cyprus insurance combination (Altius + Universal). AstroBank delivers scale (top-3 local market share ~10%) and doubled local profitability; insurance deal expected to deliver ~2% EPS accretion, >30 bps ROTCE uplift and minimal CET1 impact (~23 bps).
Revenues, Cost Control and Outlook
Revenues in line with guidance (above EUR 2.2bn for 2025); disciplined cost management with FY OpEx within EUR 870 million guidance and expected underlying cost growth of 3–4% in 2026. NII expected to surpass EUR 1.7 billion in 2026 and total revenues >EUR 2.4 billion (just under 10% growth).
Improved Provisioning Management and Cost of Risk
Management reduced overlays in Q2 and released provisions; FY cost of risk 48 bps (guidance 45 bps going forward). Quarterly impairments EUR 62 million, with QoQ C-o-R of 58 bps but underlying trend described as stable and manageable.